Although a rare tumour, comprising only about 3% of all childhood cancers in Western countries, retinoblastoma is of particular interest to geneticists and molecular biologists. It affects about one in 20,000 children, and occurs in a hereditary form in about 40% of cases. Previous studies have suggested that a predisposing germ line mutation is inherited from an affected parent in about 10% of cases and a new germinal mutation acquired in a further 30%. The remaining cases have sporadic unilateral retinoblastoma; a small proportion of these do in fact have a germinal mutation and are at risk for passing the disease to their children (Vogel, 1979) .
The pattern of inheritance is that of a dominant gene, though the mutated retinoblastoma gene behaves as a recessive gene at the cellular level. The function of the wild type allele Rb + at the retinoblastoma locus appears to be to maintain normal cellular growth control, i.e. it is a 'tumour suppressor gene'. Deletion or mutation of both alleles at this locus in a retinal cell can lead to retinoblastoma (Knudson, 1978; Murphree & Benedict, 1984; Dryja et al., 1986; Friend et al., 1986) . The hereditary form of retinoblastoma, which occurs in families where there has been a germ cell mutation of the Rb gene, is incompletely penetrant; about 10% of carriers of the mutated gene do not develop retinoblastoma.
Non-hereditary retinoblastoma is caused by two mutations to a somatic cell, and the patient is only affected unilaterally.
Patients with the hereditary form of retinoblastoma who survive after treatment for the disease have a greatly increased risk of developing second non-ocular neoplasms. In adolescence, the risk is particularly high for osteosarcoma, and the increased risk for other neoplasms has been shown to continue in later life (Abramson et al., 1984; Draper et al., 1986; Sanders et al., 1989) .
Information about nearly 1,600 cases of retinoblastoma ascertained by the Childhood Cancer Research Group (CCRG) has been used to create a registry consisting of a computer database of linked files from which information can be abstracted to enable studies of selected groups of cases and families to be carried out. Various sets of data have been selected in order to study the risks that further cases of retinoblastoma may develop in families with affected children. In particular we have studied the risk that siblings may be affected after the appearance of retinoblastoma in one child in a family, and the risk for survivors from retinoblastoma that their children will develop the disease.
Description of registry Sources of ascertainment
The Childhood Cancer Research Group has been notified of all cases of retinoblastoma registered through the National Cancer Registration Scheme in Britain from 1962 onwards.
In addition, at certain centres of treatment for retinoblastoma, all patients treated in specified periods before 1962 have been ascertained. Death certificates for patients dying from retinoblastoma in England and Wales since 1953 have been received from the Office of Population Censuses and Surveys and those for Scotland from the General Register Office. Two interview studies were carried out on the above patients as part of the Oxford Survey of Childhood Cancers: one included children dying from retinoblastoma between 1953 and 1983 and the second included children registered with the disease between 1962 and 1971. Parents of the children were interviewed in these studies by medical staff from local authority health departments and by family doctors, and information was obtained relating to all aspects of the illness and to any known family history of retinoblastoma. A further series of interviews was carried out with the parents of children born between 1965 and 1985 attending Moorfields Hospital and St Bartholomew's Hospital in London for treatment or follow up after treatment for retinoblastoma. Complete pregnancy histories for the parents were obtained in the course of these three interview studies. Surviving patients have been followed up through hospital consultants and family doctors and by 'flagging' at the National Health Service Central Registers (NHSCR): for patients flagged in this way, cancer registrations for any subsequent tumours and death certificates are received routinely from the NHSCR.
In addition to the above groups of patients, all relatives of index cases known to have had retinoblastoma or, by inspection of the pedigree, discovered to Table II shows the mean and median ages and age distribution at diagnosis for the cases in Table I . As has been reported in previous studies (Leelawongs & Regan, 1968; Matsunaga & Ogyu, 1976; Sanders et al., 1988) One of the objectives of the present paper is to determine, in families where there was a child with retinoblastoma, the risk that other children in the family would develop retinoblastoma, and thus to produce information useful for genetic counselling, based on a large number of families. Only families with at least one liveborn child in addition to the index child have been included in these analyses.
A total of 622 families with 1,905 live born children were included in the analysis. In 34 of these families there was more than one child with retinoblastoma: one family included three and one family four affected children. Two families included monozygotic twins, both of whom developed retinoblastoma; for the present analysis, each pair has been counted as a single case of retinoblastoma.
The information from these 622 families has been used to calculate the risks of retinoblastoma among the siblings of affected children classified into groups according to whether For siblings of bilaterally affected cases the probability of retinoblastoma developing by age 6 years is 44.8%, which is the figure normally quoted for the probability of retinoblastoma in families with the hereditary form of the disease (45%); for siblings of unilaterally affected cases the corresponding figure is 30%. The majority of cases have developed by age 1 year. There is strong evidence from these data that bilateral probands nearly always have bilateral siblings (47 out of 51 affected siblings being bilaterally affected) whereas unilateral probands have unilateral siblings rather more frequently than they have bilateral ones (seven out of 11).
(ii) Families where there is not a previous family history For these families the estimation procedure has to allow for the fact that there are in fact two groups, those with a previously unrecognised germ cell mutation or gonadal mosaicism, and those where the retinoblastoma in the offspring is due to a somatic mutation or a mutation in just one parental germ cell. In the first group of families it is quite likely that a second child will be born with retinoblastoma whereas this is extremely unlikely for the second group.
The probability of a subsequent child being affected has to be estimated (separately for bilateral and unilateral probands) taking into account the number of unaffected siblings in the family. (It is assumed that there is only one affected child; after a second affected sibling the family can be assigned to the old germ cell mutation category).
The method of calculation is explained in Appendix Section A3, and the results presented in Table V (Hawkins et al., 1989) . Questionnaires were sent to their family doctors requesting information about the present health of these patients, whether they had any liveborn children, stillbirths, miscarriages, or terminations of pregnancy and whether any of the children had developed retinoblastoma. One hundred and fifty-seven children were born to 89 of these patients. This study has now been extended and up-dated, bringing the numbers for whom current information about retinoblastoma survivors and their families has been obtained up to 316. A further 36 questionnaires sent to family doctors were not returned: there was thus an overall 90% positive response rate for the study.
Results
The numbers of known pregnancies, miscarriages, stillbirths and liveborn children among female survivors and partners of male survivors from retinoblastoma have been calculated aThis total excludes three children (unaffected by retinoblastoma) who died within a few days of birth. Similarly for the female patients, the one case of retinoblastoma in a child born to such a mother being added separately and not included in these calculations. bIncludes family with one child with retinoblastoma born to a survivor classified as having sporadic unilateral retinoblastoma.
As with the study of other pregnancies among parents of children with retinoblastoma we thought it possible that survivors of retinoblastoma might have an increased miscarriage or stillbirth rate. However there was no evidence of such an increase.
Discussion
A considerable range of figures has been published concerning the proportions of unilateral/bilateral cases and hereditary/non-hereditary cases of retinoblastoma. On the basis of the large numbers of cases of retinoblastoma presented in this paper diagnosed between 1962 and 1985, a period for which we believe we have good ascertainment, and where the cases have been followed up through family doctors and clinicians to verify the diagnosis and family history, we suggest that the distribution of cases in Britain is as follows.
Bilateral cases represent 40% of the total number; of these 28% have a family history at the time of diagnosis. Of the 60% of cases which are affected unilaterally, 7% have a previous family history. In all, 15% of cases have a family history of retinoblastoma at the time of diagnosis. Our suggested proportions of 44% hereditary and 56% non-hereditary cases may be subsequently affected by further cases of retinoblastoma appearing in the families of those who on present information are placed in the sporadic non-hereditary category.
The proportion of bilaterally affected cases in this study (40%) is higher than that reported in many other studies. Some studies are subject to selection bias and not too much reliance should be placed on the proportions quoted. However, the Surveillance, Epidemiology and End Results (SEER) study of children's cancer in the United States includes 220 cases of retinoblastoma ascertained from nine population based registries, and the proportion of bilateral cases quoted in this study was only 25% (Tamboli et al., 1990) . It is possible that some of the cases originally ascertained as unilateral in this study later developed tumours in the other eye. Among 550 cases ascertained in the Netherlands, 31% were found to be bilateral (Schappert-Kimmijser et al., 1966) , and in a study of 899 cases of retinoblastoma in France, 34% were bilateral (Bonaiti-Pellie, 1976 ).
For comparison with our figure of 44% for the proportion of all hereditary cases, Der Kinderen et al. (1988) It has been suggested that the proportion of hereditary cases in the population will increase with improved survival (Vogel, 1979) . We have not observed this in our figures (see Table I ), but are not able to obtain reliable population based data for the years before 1962.
Age at diagnosis The data on average age at diagnosis in Table II confirm and extend those from previous studies. It is well recognised that patients with the hereditary form of retinoblastoma tend to be diagnosed earlier than those with the non-hereditary form and that bilateral cases tend to be diagnosed earlier than unilateral ones; since bilateral cases are hereditary and unilateral cases mainly non-hereditary these two comparisons to some extent overlap. In Table II we have attempted to separate the two effects. The first two columns compare hereditary unilateral and bilateral cases. A possible explanation of the difference between bilateral and unilateral cases is that the occurrence of bilateral disease may be an indication that the individual or family is more susceptible, or more exposed to mutagenic agents, than those where the disease is unilateral; retinoblastoma would be expected to develop earlier in the former. For hereditary cases without a family history (new germ cell mutations) the bilateral cases are diagnosed later than those with a family history; this may simply be a consequence of the fact that these patients would not have had the regular eye examination that those with a family history have.
Non-hereditary unilateral cases are on average diagnosed later than any of the other groups. This is well recognised and can be predicted as a consequence of the hypothesis that such cases have to accumulate two somatic mutations rather than one before retinoblastoma develops (Knudson, 1978 family. This average risk has been assessed by Vogel (1979) as 6% after the birth of a bilateral sporadic case and 1% after the birth of a unilateral sporadic case. From our study of families where, apart from the index child, there was no family history of retinoblastoma, we conclude that if there is just one affected child and no unaffected children in the family the risk that the next child will be affected is 2% for siblings of a bilaterally affected child and about 1% for siblings of a unilaterally affected child. As explained in the Section 'Sibships of retinoblastoma cases: Results (ii)' and 'Appendix A3', these risks are lower if there are also some unaffected children in the family. This latter point is referred to but not discussed by Vogel whose estimates appear to be averages taken over all sibship sizes. Taking this into account, our estimate for siblings of sporadic unilateral cases is rather lower than Vogel's; allowing for the degree of uncertainty in the estimates they are consistent with each other. Our estimate for siblings of sporadic bilateral cases is considerably lower than Vogel's, particularly since it again relates to a sibling of an only, affected, child (the type of family for which the estimated risk to a subsequent child is highest) while Vogel's is an average for different family sizes.
Risks to offspring
In this part of the study, the likelihood of passing on the mutated retinoblastoma gene to their children is assumed to be the same for both old germ cell and new germ cell (sporadic bilateral) cases of retinoblastoma. Among 75 children born to the 44 survivors with the hereditary form of retinoblastoma who had liveborn children 32 developed retinoblastoma. Using life-table methods it can be estimated that the proportion developing retinoblastoma by age 6 years is 43.5%, giving a penetrance of 87%. Again this is very close to the usual assumption of a 90% penetrance.
The analysis in the Section 'Offspring of retinoblastoma cases: Results' and 'Appendix Section A4', suggests that for children born to survivors from unilateral sporadic retino-blastoma the risk is about 1%, the proportion of unilateral sporadic cases who are in fact carrying the retinoblastoma gene being estimated as about 2%. This value updates the previous estimate, given in Hawkins et al. (1989) , which was based on an earlier analysis of a subset of the cases in the present paper. The estimated risk to subsequent children after the birth of an affected child is of course the same as that for other parents with hereditary retinoblastoma. Again, for each unaffected child born to a possible carrier the estimated probability that subsequent children will be affected decreases.
For unilateral sporadic cases, Vogel (1979) has suggested that between 10% and 12% of such cases are caused by germ cell mutations and therefore that about 5% of their children may be affected with retinoblastoma. Vogel bases his estimate, which is the one nearly always quoted for genetic counselling, on the joint results from seven separate studies, the largest study (Schappert-Kimmijser et al., 1966) , giving a particularly high rate of affected children in the families of survivors from unilateral sporadic retinoblastoma. If the selection of cases included in some of these seven studies was biased this could lead to an overestimate of the risk: such bias could arise for instance if unilateral sporadic probands were included in a series after being ascertained through an affected offspring. Again, if inadequate family histories were obtained cases could be wrongly classified as sporadic.
Non-ocular tumours It is well known that survivors of hereditary retinoblastoma have a greatly increased risk of developing a variety of other tumours (Draper et al., 1986; Sanders et al., 1989) and it has been suggested that there may be an increased risk even among unaffected family members. In the present study we found two cases of childhood cancer, one osteosarcoma and one acute lymphoblastic leukaemia among 1,246 unaffected siblings in retinoblastoma families, both occurring among the 698 siblings of sporadic non-hereditary cases. This represents a rather higher incidence than that found in the general population but cannot necessarily be considered as evidence of an increased risk in non-carriers, particularly as it seems reasonable in view of the well known association between retinoblastoma and osteosarcoma to speculate that the case of osteosarcoma might have arisen in a child with unexpressed retinoblastoma.
In the study of offspring, one of the 217 children identified in the follow-up studies developed a testicular teratoma. This, together with a case of a sib of a patient with sporadic unilateral retinoblastoma who developed a teratoma of the testis (included in the registry but not in this study) raises the question of whether there is a real association between these two conditions. We have also noted that a child born to a survivor from sporadic unilateral retinoblastoma died from neuroblastoma. We do not know of any previous reference to an association between these two neoplasms and this may well be a chance finding.
Genetic counselling
The results of this paper are obviously relevant to problems of genetic counselling. For patients with hereditary retinoblastoma our findings agree with the generally quoted risk of retinoblastoma to their offspring of 45% -arising from a 50% risk of inheriting the retinoblastoma gene, together with a penetrance of 90%. The risks to various types of relative can be calculated in the same way as for any dominant gene; see for example the discussion in Harper (1988) Chapter 2.
The risks for patients with sporadic unilateral retinoblastoma and their relatives appear to be much smaller than the estimates quoted in earlier papers. As explained above most of these estimates seem to be based on Vogel's (1979) review and there is some uncertainty about the selection of cases in the series on which he bases his estimates. Our estimate of the probability that a unilateral sporadic case is in fact a gene carrier is about 2%, perhaps higher if the case has no siblings, and decreasing as the number of unaffected siblings increases. The probability that the gene will be transmitted to the children of such patients is about 1%. The estimated risk for a sibling of a unilateral sporadic case, when there are no other siblings, is similar. Again this risk decreases as the number of unaffected siblings increases. For siblings of patients with bilateral retinoblastoma our estimate of the risk is about 2%, less if there are already unaffected siblings; this is lower than that of Vogel, which was based on the study by Briard-Guillemot et al. (1974) , of about 6%. It is not clear whether the substantial difference between these estimates is due to the fact that both are rather imprecise or whether in the Briard-Guillemot study some family histories were missed and the cases wrongly classified as sporadic.
Genetic counselling for other relatives of these patients can again be based on standard methods for such diseases (Harper, 1988, Chapter 2) .
With recent developments in molecular genetics it is of course possible, in certain situations, to make considerably better risk estimates:
(i) Where at least two family members are affected it is possible, using restriction fragment length polymorphisms (RFLPs) to apply standard methods of genetic linkage analysis to identify gene carriers with a high degree of certainty; the range of RFLPs now available mean that the great majority of families will be informative using this method (Wiggs et al., 1988) . These techniques have been applied both prenatally and postnatally (Onadim et al., 1990) .
(ii) Even for sporadic cases it may be possible to distinguish between hereditary and non-hereditary cases using the approach described by Yandell et al. (1989) which involves the direct identification of point mutations in the retinoblastoma gene and compares tumour cells with constitutional cells. Cowell (1991) in a review of the molecular genetics of retinoblastoma stated that identification of all gene carriers in retinoblastoma families will soon be possible. This would mean that the frequent ophthalmological examinations under anaesthetic of all children of affected parents and other relatives of retinoblastoma patients would no longer be necessary, and clinical resources could be concentrated on patients who are carriers. This paper is based on information provided by cancer registries, hospital consultants and family doctors in Britain. We would like to thank them, and are especially grateful to the parents of children included in this study who agreed to be interviewed and to give information about their families; the data from some of these interviews was kindly made available to us by the staff of the Oxford Survey of Childhood Cancer in Birmingham. The Office of Population Censuses and Surveys, the Information and Statistics Division of the Common Services Agency of the Scottish Health Service, the Registrar General for Scotland and Regional Cancer Registries all provided notifications of retinoblastoma cases, and we are grateful to them. We would also like to thank Dr M. Jay and Dr J.E. Kingston of Moorfields and St Bartholomew's Hospitals for information provided about patients and their families. We are grateful to Mrs K. Bunch, Mrs E. Mowat, Mrs E. Roberts and Mr M. Loach for help with setting up the database, collection of data and computer calculations.
We are grateful to one of the referees for suggestions on the analysis of the risks to siblings and for pointing out that our results had implications for the estimation of the proportions of nonpenetrant cases of hereditary retinoblastoma.
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APPENDIX: STATISTICAL METHODS
In Section Al, A2, A3 we give details of the statistical methods used to estimate the risks to siblings of affected cases and to offspring of parents known to have the hereditary form of retinoblastoma. In Section A4 we explain the method used to estimate the proportion of hereditary cases among sporadic unilateral cases, on the basis of the number of cases of retinoblastoma observed in their offspring Al Risks to offspring of hereditary cases For simplicity we discuss first the estimation of the risk for offspring of hereditary cases. Virtually all cases of retinoblastoma become apparent by age 10 years; thus if all offspring were followed up to age 10 the proportion of affected cases would be simply the ratio of affected cases to total offspring. Since in practice the length of follow-up varies it is necessary to use actuarial, or life-table, methods in estimating the risk (see e.g. Peto et al., 1976; . This method is routinely used in clinical trials where patients are followed-up for differing lengths of time and where the length of survival to death or relapse is allowed for in the analysis. The essence of the method is that if we are interested in, say, mortality 5 years after treatment we cannot classify patients who have only been followed up for 3 years and are alive at that time; but they do, for the first 3 years, contribute to the denominator of those at risk for the first 3 years, and therefore must be taken into account in calculating the risk up to that point since this affects the risk at 5 years. Similarly, in the present analysis, offspring known to be alive at 3 years (but then lost to follow-up) contribute to the denominators of persons at risk up to that age, but not thereafter. In Table VI For the risks to siblings in these families it is necessary to take into account the fact that in some of the families with more than one affected child, the sibship was ascertained independently through two or more of these affected children. (This point is discussed in, for example, Cavalli-Sforza & Bodmer, 1971) . If, for instance, the family contains two independently ascertained affected siblings A and B, and two unaffected siblings C and D the family contributes twice to the analysis as follows: first, regarded as siblings of A there are three siblings, B, C and D at risk, one of whom, B is affected; secondly, regarded as siblings of B, sib A is affected, C and D are unaffected. With this interpretation of the at-risk population the analysis proceeds in the same way as that for the offspring described above. The standard errors calculated from the life-table analysis (though again calculated according to the conservative method which overestimates the error of the usual life-table method) do not take the double ascertainments into account and this will lead to an underestimation. By analogy with the situation where all cases are identified during the period of follow-up, i.e. where actuarial methods are not necessary, it seems likely that the standard error is not more than 40% greater than the value quoted here the data on families of different size, but in practice the numbers of cases available are far too small for this approach; the method described here makes use of all the data to estimate the probability, x,, that for a family with one sporadic case and no unaffected cases the family is carrying an old germ cell mutation (in which we include the possibility of gonadal mosaicism). The other probabilities of interest can be derived from xl. For a family with two children of whom one is a sporadic case and one is unaffected let x2 be the probability that there is an old germ cell mutation. In general denote this probability by x, if one of a family of s children is affected. Let p be the probability of an affected case occurring if the family is carrying an old germ cell mutation. On the basis of the results given in Table IV we assume that, for such families, if there is already an affected case, p = 0.45 if the case is bilateral and 0.3 if it is unilateral; let q = 1 -p.
Obviously, for a family with one out of s children affected the probability that there is not an old germ cell mutation is 1 -x,. In this case the probability that the next child will not be affected is, say, r, which is almost equal to unity.
The probability x, does not depend on which one of the s children is affected and is, in particular, the probability that there is an old germ cell mutation, given that one of the first s -1 children is affected and the Sth one is not.
Then, by Bayes' Theorem s = qxs.l qxs.. + r(l-xs.) From previous data and from the present study xi is small and r is very nearly equal to one; thus s qx -I Xs..q .XI The probability, y, that the (s + I)th child will be affected is px, and, obviously, y, qS -ly1-If there are ns families with s children of whom one is affected and who go on to have a further child, and if as of these children are affected we may estimate y, by as/n, and y1 by as/(nsqs -), i.e. we can obtain an estimate of y1 for each value of s.
The variances of these estimates are {var (a,))/(ns2q2s 2) and, taking as as a Poisson variable, this is approximately as/n,2q2s-2. The expected value of this expression is y1/n,qs ', i.e. the variances for families of different sizes are approximately inversely proportional to nqs -and thus the combined estimate for y, using data from all the families is y, = a5/En,qs-' y, is the estimated risk for subsequent siblings in families with one affected child and no unaffected ones. For a family of size s with one affected child and s -1 unaffected siblings the risk ys = qS-'y1 can be estimated, given y, and q.
For families of size 1, 2, 3, .
s, and just one affected case, the proportions with unrecognised germ cell mutations are x, = y,/p, qx1, q2xi qS -Ixi.
A4 Estimation of proportion of hereditary cases among sporadic unilateral retinoblastoma cases
There is at present no direct and generally applicable method of classifying sporadic unilateral retinoblastoma cases as hereditary and non-hereditary though advances in molecular genetics may soon make this possible. If we wish to estimate the proportion of genecarriers in this group it is necessary to use information on their offspring. The method of estimation described below takes into account the fact that, for instance, a survivor with four unaffected children is less likely to be a gene carrier than one for whom there is only one unaffected child. We denote the unknown proportion of unilateral sporadic cases that actually have the hereditary form by A. This parameter and its standard error may be estimated using the method of maximum likelihood.
Let T be the total number of families in which one parent has unilateral sporadic retinoblastoma, n be the total number of children in a family, and r the number with retinoblastoma. Let u be the probability of retinoblastoma developing in a child if a parent is a gene carrier and v the probability otherwise. We assume that all children are followed up at least to the age by which all retinoblastomas will be diagnosed.
The likelihood of the observed data is H (n) [A. ur (1 _ U)nr + (l_)vr(l -V)nthe product being taken over the values of n and r for each of the T families. For the present study the values of the n are shown in Table VII ; all of the values of r, except one, are zero; in one family r = n = 1. Assuming the risk to the offspring is the same for unilaterally affected parents as it is for bilaterally affected parents, u = 0.45. The risk in the general population, v, is less than 1 in 20,000 and 1 -vc.1.
For families where r = 0, h -11/(0.55n -1) For the family with r= n = 1, h 0. Solving this equation gives an estimate of 0.0169 for the value of A, with an estimated standard error, using the usual maximum likelihood method, of 0.0168. This standard error and that in the next paragraph are based on small numbers and it seems unlikely that the usual normal approximation is valid; they should be regarded as giving only a general idea of the precision of the estimates.
If we assume that the risk to the offspring of unilaterally affected parents with hereditary retinoblastoma is the same as that for the siblings of unilateral hereditary cases then, from the first part of Table IV , u = 0.3. Repeating the above calculations with this value of u gives an estimate of 0.0231 with a standard error of 0.0230.
